As the world continues to grapple with the COVID-19 pandemic, healthcare stocks have become a hot commodity for investors. With the demand for medical supplies and treatments on the rise, it's no surprise that many are looking to invest in this sector. However, not all healthcare stocks are created equal. To help you make informed decisions, we spoke to a pro who revealed the healthcare stocks that are worth buying right now. First on the list is Johnson & Johnson (JNJ). This pharmaceutical giant has been around for over 130 years and has a diverse portfolio of products, including medical devices, pharmaceuticals, and consumer health products. JNJ has a strong track record of delivering consistent returns to investors and has a dividend yield of 2.5%. With the company's recent acquisition of Momenta Pharmaceuticals, JNJ is poised to continue its growth trajectory. Next up is UnitedHealth Group (UNH), the largest health insurer in the United States. UNH has a market cap of over $300 billion and has consistently delivered strong earnings growth. The company's Optum segment, which provides healthcare services and technology solutions, has been a major driver of its success. UNH also has a dividend yield of 1.5%, making it an attractive option for income investors. Another healthcare stock worth considering is Teladoc Health (TDOC), a telemedicine company that allows patients to connect with healthcare providers remotely. With the pandemic forcing many to stay at home, telemedicine has become increasingly popular. TDOC has seen a surge in demand for its services and has reported strong earnings growth. The company recently acquired Livongo, a digital health platform that helps people manage chronic conditions, which is expected to further boost its growth prospects. Last but not least is Moderna (MRNA), a biotech company that has been at the forefront of developing a COVID-19 vaccine. MRNA's vaccine has shown promising results in clinical trials and has received emergency use authorization from the FDA. The company's mRNA technology platform has also shown potential in developing treatments for other diseases. While MRNA is a riskier investment compared to the other stocks on this list, its potential for growth is significant. In conclusion, healthcare stocks are a smart investment choice in today's market. However, it's important to do your research and choose stocks that have strong fundamentals and growth prospects. Johnson & Johnson, UnitedHealth Group, Teladoc Health, and Moderna are all worth considering for your portfolio. As always, it's important to consult with a financial advisor before making any investment decisions.